Titlebook: Cardiovascular 3D Printing; Techniques and Clini Jian Yang,Alex Pui-Wai Lee,Vladimiro L. Vida Book 2021 Chemical Industry Press 2021 3D pri

只看該作者 · 發(fā)表于 2025-3-25 03:46:12

Selection of Cardiovascular 3D Printing Materials,umable items, such as stent, valve, tissue engineered scaffold, and other consumable items that can mimic physiological function of the heart [5, 6]. Therefore, the future development direction of cardiovascular medical 3D printing will focus on bio-printing that can generate the circulatory system, which can transport blood and nutrients.

只看該作者 · 發(fā)表于 2025-3-25 08:24:03

只看該作者 · 發(fā)表于 2025-3-25 13:56:46

3D Printing for LAA Occlusion,nd ensure filling of the left ventricle (LV). In cardiovascular diseases, the LAA is the main site of thrombus formation because of its special anatomical structure and functional characteristics. Thrombi originating from the LAA account for 90% of atrial thrombi in nonvalvular atrial fibrillation [2].

只看該作者 · 發(fā)表于 2025-3-25 16:23:19

https://doi.org/10.1007/978-94-009-7099-13D printing technology also enables manufacturers to print prototypes more quickly, making it easier to evaluate and test products before they are finalized. The first step of 3D printing is using computer-aided design (CAD) software to create a 3D model, followed by using a 3D printer to print the model itself.

只看該作者 · 發(fā)表于 2025-3-25 20:27:29

只看該作者 · 發(fā)表于 2025-3-26 03:13:14

只看該作者 · 發(fā)表于 2025-3-26 05:52:05

Tokuko Haraguchi,Yasushi Hiraokalignant tumors. According to previous reports, three-fourths of all cardiac tumors are benign tumors, nearly half of which are myxomas, with the other half being lipomas, papillary fibroelastoma, and rhabdomyomas; most malignant tumors were undifferentiated sarcomas, followed by angiosarcoma, rhabdomyosarcoma, lymphoma, and so on [2].

只看該作者 · 發(fā)表于 2025-3-26 09:33:22

只看該作者 · 發(fā)表于 2025-3-26 15:17:44

3D Printing of Cardiac Tumors,lignant tumors. According to previous reports, three-fourths of all cardiac tumors are benign tumors, nearly half of which are myxomas, with the other half being lipomas, papillary fibroelastoma, and rhabdomyomas; most malignant tumors were undifferentiated sarcomas, followed by angiosarcoma, rhabdomyosarcoma, lymphoma, and so on [2].

只看該作者 · 發(fā)表于 2025-3-26 20:34:26

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛(ài)論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-16 08:39
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved